• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
On September 9th, it was reported that from September 5th to 8th, the National Healthcare Security Administration organized on-site price negotiations for the 2026 National Basic Medical Insurance Drug Catalog. Over a hundred domestic and foreign companies participated, and 124 drugs not currently on the catalog were shortlisted for the negotiation stage. Innovative drugs in key areas of public concern, such as oncology, rare diseases, chronic diseases, and pediatric medications, participated in the negotiations and are expected to be included in the medical insurance catalog. Simultaneously, the adjustment of the commercial health insurance innovative drug catalog was also carried out, with 12 drugs shortlisted for on-site price negotiations. The 2026 National Medical Insurance Drug Catalog and the commercial health insurance innovative drug catalog are expected to be released in November this year and officially implemented on January 1, 2027.The mayor of Novorossiysk, Russia, said that the attack on the city by Ukraine resulted in four deaths.The Ministry of Justice of Kazakhstan: Enforcement actions against the North Caspian Oil Corporation are ongoing.Gatwick Airport, UK: Flights at London Gatwick Airport have now resumed. We still expect it will take some time for operations to fully return to normal.1. New CEOs Debut – Ternus, who has served as Apples head of hardware since 2021, has hosted numerous Apple product launches, but this will be his first appearance as CEO. This event will be his first opportunity to showcase his vision for the company. 2. The Long-Standing Issue of iPhone Price Increases – Pricing of the new products is perhaps one of the most anticipated issues at this event. Apple has taken measures this year to mitigate the impact of rising chip prices, and it is reported that it will raise the prices of the iPhone 18 Pro and iPhone 18 Pro Max by $100 each, a smaller increase than previously expected. 3. First Foldable iPhone – Apple is reportedly naming its first foldable phone the "iPhone Duo," with a starting price of $2,000. The entry-level version will come with 256GB of storage, and Apple will also release a larger capacity version, with the highest price potentially reaching around $3,000. This phone is expected to launch as early as October, offering white and dark blue color options. 4. iPhone 18 Pro Series – The iPhone 18 Pro series will look almost identical to the 17 Pro series, with one major change being the replacement of the orange color with a burgundy. However, in terms of cameras, the 18 Pro series will feature a new lens and professional-grade imaging software. A mechanical aperture may be added to the larger models, enabling more precise depth-of-field control and improving low-light performance. Furthermore, the "Isle of Light" design will be further reduced, and the series will feature the A20 Pro chip and a redesigned vapor chamber for better heat management. 5. Apple Watch and AirPods 5 – For the new Apple Watch Series 12 and Ultra 4, Apple will introduce new colors and redesign the case and band. The Series 12 will return to a ceramic case version; the Ultra 4 will have longer battery life. Additionally, Apple will introduce the entry-level AirPods 5, featuring significantly upgraded active noise cancellation. 6. Other potential new products: A home hub for controlling smart home devices, a new Apple TV with a faster processor, and a HomePod mini. Additionally, Apple is expected to announce the official release dates for iOS 27, iPadOS 27, macOS Golden Gate, tvOS 27, watchOS 27, and visionOS 27. 7. Products not expected to be released: According to media reports, the standard iPhone 18 will be delayed until next spring; in-ear AirPods will be delayed until next year; a MacBook Pro with an M6 chip and a new iMac may be released before the end of this year; a new MacBook Pro with an OLED touchscreen may be released at the end of this year or early next year; and an OLED iPad mini is expected to be released before the end of October.

USD/CHF Consolidates in a Range of 0.9320-0.9350 on Expectations of Rate Reversion to Neutral

Drake Hampton

Apr 08, 2022 09:57

Tips

  • USD/CHF remained stuck around 0.9350 despite a big increase in US Treasury yields.

  • The DXY is aiming for 100.00 as traders increase their expectations for an aggressive rate hike.

  • Russia resigns from the United Nations Human Rights Council.

 

Since Thursday, the USD/CHF pair has been swinging within a narrow band of 0.9318-0.9348 as Federal Reserve (Fed) policymakers have begun prescribing a reversion to neutral rates from ultra-loose monetary policy postures.

 

After commenting on the amount to which the Fed will raise interest rates in future monetary policies, members of the Fed's Monetary Policy Committee (MPC) have changed their focus to calling for a return to neutral policy. The ultra-loose monetary policies and helicopter money used to boost growth following the Covid-19 outbreak have served their purpose, and it would be preferable to return to normal rates and a self-sufficient economy. Atlanta Fed President Raphael Bostic stated on Thursday that while it is quite acceptable for the Fed to move policy closer to neutral, it should go cautiously, according to Reuters.

 

On the Russia-Ukraine front, Russia is expelled from the United Nations (UN) Human Rights Council after its members voted against the Kremlin's war crimes in Bucha, Ukraine. Additionally, US lawmakers have decided to prohibit Moscow from importing oil, gas, and coal. Additionally, the former has opted to revoke its 'Most Favored Nation' trade designation, resulting in higher tariffs for Moscow.

 

Meanwhile, the US dollar index is heading towards the enchanted level of 100.00, fueled by forecasts for better US Consumer Price Index (CPI) data next week. The yield on the 10-year US Treasury note has recaptured a three-year high of 2.66 percent as rate rise worries resurface.

USD/CHF

image.png